The Food and Drug Administration is requiring labeling changes for all opioid analgesics used in the outpatient setting, to provide additional guidance on safe opioid tapering.
The current evidence for the efficacy and safety of replacing opioids with medical cannabis for treating opioid addiction does not meet standards for recommendation.
Veterans who received opioid prescriptions from both the VA and Medicare Part D providers were more likely to unintentionally but fatally overdose on opioids.
In a draft report issued December 28, 2018 by the US Department of Health and Human Services-sponsored Pain Management Best Practices Inter-Agency Task Force, recommendations for a multidisciplinary approach to pain management were formulated.
A one-time education program regarding safe, responsible opioid prescribing for clinicians prescribing these medications for the management of acute pain may effectively improve their knowledge and confidence, and may increase guideline adherence.
Researchers found that the prevalence of opioid prescriptions varied nearly 300% across the race/ethnicity-income gradient.
The rate of pediatric mortality associated with prescription and illicit opioids rose 3-fold between 1999 and 2016.
This rise in prescribing of prescription opioids in the last 2 decades of the 20th century occurred at a time during which medical professionals were urged to resort to prescription opioids to manage untreated and chronic noncancer pain.
The American Heart Association launched in December 2018 a 30 minute-long online course titled “Opioid Education for Healthcare Providers.”
As the government shutdown drags in to its second month, physicians who treat opioid use disorders are being backed against a wall.
